Viewing Study NCT00461266


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2025-12-27 @ 10:49 AM
Study NCT ID: NCT00461266
Status: WITHDRAWN
Last Update Posted: 2016-08-24
First Post: 2007-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module